Non-Hodgkin Lymphoma by Clinical Course

Non-Hodgkin Lymphoma by Clinical Course — Trials · CancerIndex

Clinical trials

Registered studies

1,200 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 346
Recruiting: 173
Ph III recruiting: 8
Growth YoY: +32.7%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (209)

clinicaltrialsPublishedShowing 1–12 of 12 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04097067	ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma	unknown	N/A	83	University Hospital MuensterOTHER	1	Aug 27, 2024	clinicaltrials
NCT05904522	Histopathological Changes in Mycosis Fungoides	unknown	N/A	10	Bezmialem Vakif UniversityOTHER	1	Feb 13, 2024	clinicaltrials
NCT04582487